Home » Topics » BioWorld Science

BioWorld Science
RSS

Limitations of certain mouse models for sickle cell research highlighted

July 8, 2022

Researchers develop a hepatitis E model in rats

July 8, 2022

Oral and topical CF-602 significantly reduces erectile dysfunction in vivo

July 8, 2022

GLP-1R agonist PF-1801 seen useful to treat polymyositis

July 8, 2022

DS-17701585, EP300/CBP inhibitor with efficacy in lung squamous cell carcinoma xenograft

July 8, 2022

Aramchol shows effects in preclinical models of lung and gastrointestinal fibrosis

July 8, 2022

Explant glioblastoma model may allow early precision treatment of patients

July 8, 2022

Novel vaccination strategy using AMP-CpG against EBV infection shows promise in vivo

July 8, 2022

New ROCK-1/2 inhibitors identified at Chiesi Farmaceutici

July 8, 2022

Shanghai Institute of Materia Medica describes thyroid hormone receptor agonists

July 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...